Proposal for change to medicinal products by changing the /1 hour normalization of patch products to usual manufacturer’s stated strength commonly /24 hours (or /1 hour or /16 hours or /72 hours may be appropriate). Do we have consensus in the DEUSG about how this should be represented in the international edition? For example, concentration strength (eg. moving away from normalized /1) or presentation strength - how would this work? - or something else (rate etc)?